BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9369226)

  • 21. Determination of Gab1 (Grb2-associated binder-1) interaction with insulin receptor-signaling molecules.
    Rocchi S; Tartare-Deckert S; Murdaca J; Holgado-Madruga M; Wong AJ; Van Obberghen E
    Mol Endocrinol; 1998 Jul; 12(7):914-23. PubMed ID: 9658397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 60-kilodalton protein in rat hepatoma cells overexpressing insulin receptor was tyrosine phosphorylated and associated with Syp, phophatidylinositol 3-kinase, and Grb2 in an insulin-dependent manner.
    Zhang-Sun G; Yang C; Viallet J; Feng G; Bergeron JJ; Posner BI
    Endocrinology; 1996 Jul; 137(7):2649-58. PubMed ID: 8770882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphatidylinositol 3'-kinase associates with an insulin receptor substrate-1 serine kinase distinct from its intrinsic serine kinase.
    Cengel KA; Kason RE; Freund GG
    Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):397-404. PubMed ID: 9761740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional trans-inactivation of insulin receptor kinase by growth-inhibitory angiotensin II AT2 receptor.
    Elbaz N; Bedecs K; Masson M; Sutren M; Strosberg AD; Nahmias C
    Mol Endocrinol; 2000 Jun; 14(6):795-804. PubMed ID: 10847582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrosine phosphatase SHP-2 binding to CTLA-4: absence of direct YVKM/YFIP motif recognition.
    Schneider H; Rudd CE
    Biochem Biophys Res Commun; 2000 Mar; 269(1):279-83. PubMed ID: 10694513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A unique insert in the linker domain of Syk is necessary for its function in immunoreceptor signalling.
    Latour S; Zhang J; Siraganian RP; Veillette A
    EMBO J; 1998 May; 17(9):2584-95. PubMed ID: 9564041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosine phosphorylation of beta-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins.
    Sotgia F; Lee H; Bedford MT; Petrucci T; Sudol M; Lisanti MP
    Biochemistry; 2001 Dec; 40(48):14585-92. PubMed ID: 11724572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Src homology 2 domains of protein tyrosine phosphatase are associated in vitro with both the insulin receptor and insulin receptor substrate-1 via different phosphotyrosine motifs.
    Ugi S; Maegawa H; Olefsky JM; Shigeta Y; Kashiwagi A
    FEBS Lett; 1994 Mar; 340(3):216-20. PubMed ID: 7510639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The amino-terminal Src homology 2 domain of phospholipase C gamma 1 is essential for TCR-induced tyrosine phosphorylation of phospholipase C gamma 1.
    Stoica B; DeBell KE; Graham L; Rellahan BL; Alava MA; Laborda J; Bonvini E
    J Immunol; 1998 Feb; 160(3):1059-66. PubMed ID: 9570517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin stimulates the tyrosine dephosphorylation of docking protein p130cas (Crk-associated substrate), promoting the switch of the adaptor protein crk from p130cas to newly phosphorylated insulin receptor substrate-1.
    Sorokin A; Reed E
    Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):595-600. PubMed ID: 9729467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tyrosine-614, the major autophosphorylation site of the receptor tyrosine kinase HEK2, functions as multi-docking site for SH2-domain mediated interactions.
    Hock B; Böhme B; Karn T; Feller S; Rübsamen-Waigmann H; Strebhardt K
    Oncogene; 1998 Jul; 17(2):255-60. PubMed ID: 9674711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FcgammaRII tyrosine phosphorylation differs between FcgammaRII cross-linking and platelet-activating anti-platelet monoclonal antibodies.
    Qi R; Ozaki Y; Asazuma N; Satoh K; Yatomi Y; Law CL; Hato T; Nomura S
    Biochim Biophys Acta; 1999 Sep; 1451(2-3):353-63. PubMed ID: 10556589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of SH2-containing protein tyrosine phosphatase 2 with the insulin receptor and the insulin-like growth factor-I receptor: studies of the domains involved using the yeast two-hybrid system.
    Rocchi S; Tartare-Deckert S; Sawka-Verhelle D; Gamha A; van Obberghen E
    Endocrinology; 1996 Nov; 137(11):4944-52. PubMed ID: 8895367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
    Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
    Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors.
    Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M
    Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of major tyrosine phosphorylation sites in the human insulin receptor substrate Gab-1 by insulin receptor kinase in vitro.
    Lehr S; Kotzka J; Herkner A; Sikmann A; Meyer HE; Krone W; Müller-Wieland D
    Biochemistry; 2000 Sep; 39(35):10898-907. PubMed ID: 10978177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of SH2 containing proteins to the insulin receptor: a new way for modulating insulin signalling.
    Liu F; Roth RA
    Mol Cell Biochem; 1998 May; 182(1-2):73-8. PubMed ID: 9609116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lumenal and transmembrane domains play a role in sorting type I membrane proteins on endocytic pathways.
    Reaves BJ; Banting G; Luzio JP
    Mol Biol Cell; 1998 May; 9(5):1107-22. PubMed ID: 9571243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tyrosine-phosphorylated forms of Ig beta, CD22, TCR zeta and HOSS are major ligands for tandem SH2 domains of Syk.
    Wienands J; Freuler F; Baumann G
    Int Immunol; 1995 Nov; 7(11):1701-8. PubMed ID: 8580068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site.
    van der Geer P; Wiley S; Pawson T
    Oncogene; 1999 May; 18(20):3071-5. PubMed ID: 10340378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.